AC
AMGN icon

AlphaCore Capital’s Amgen AMGN Stock Holding History

AlphaCore Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.76M Sell
13,140
-3,702
-22% -$1.27M 0.09% 194
2026
Q1 		$5.93M Buy
16,842
+2,203
+15% +$785K 0.14% 131
2025
Q4 		$4.79M Buy
14,639
+4,818
+49% +$1.53M 0.11% 167
2025
Q3 		$2.77M Sell
9,821
-1,547
-14% -$449K 0.09% 167
2025
Q2 		$3.17M Buy
11,368
+2,633
+30% +$746K 0.12% 133
2025
Q1 		$2.72M Buy
8,735
+4,534
+108% +$1.34M 0.23% 92
2024
Q4 		$1.09M Buy
4,201
+195
+5% +$57.9K 0.24% 72
2024
Q3 		$1.29M Buy
4,006
+470
+13% +$154K 0.29% 63
2024
Q2 		$1.1M Buy
3,536
+2,471
+232% +$726K 0.27% 65
2024
Q1 		$303K Buy
+1,065
New +$312K 0.08% 126
2020
Q2 		– Sell
-45
Closed -$9K – 82
2020
Q1 		$9K Buy
+45
New +$9.83K 0.01% 220

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AlphaCore Capital's AMGN Position: Q2 2026 in Review

AlphaCore Capital reduced its Amgen (AMGN) stake by 22% in Q2 2026, selling an estimated $1.27M and leaving 13,140 shares worth $4.76M. The position accounts for 0.09% of the portfolio, ranked #194.

AlphaCore Capital first reported a position in AMGN in Q1 2020 and has held it in 11 quarters since. The position peaked at $5.93M in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AlphaCore Capital held 13,140 shares of Amgen worth $4.76M as of Q2 2026.
  • AlphaCore Capital sold 3,702 Amgen shares in Q2 2026, an estimated $1.27M.
  • Amgen made up 0.09% of AlphaCore Capital's portfolio in Q2 2026, its #194 holding.
  • AlphaCore Capital first reported a position in Amgen in Q1 2020 and has held it in 11 quarters since.
  • AlphaCore Capital's Amgen position peaked at $5.93M in Q1 2026.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.